Indian ADRs ended mixed. Satyam shot up 41.41% or $ 0.82, to $ 2.8. In the banking space, ICICI Bank was down 2.81% or $ 0.43, to close at $ 14.85/sh and HDFC Bank fell 2.19% or $ 1.48 …

Read More..

According to Nirmal Bang’s report, the markets continued their positive momentum amid volatility. The Sensex closed up 186 points or 1.80% at 10534 and the Nifty was up 45 points or 1.42% at 3,256. Nirmal Bang’s report …

Read More..

PINC Research has recommended a buy rating on Petronet LNG Ltd with a price target of Rs 66 in its April 06, 2009 research report. “Petronet LNG Ltd. (PLL) accounts for 23% of natural gas supply of India and boasts of a sovereign parentage of GAIL, IOCL, ONGC and BPCL. …

Read More..

Sharekhan has maintained its buy rating on Piramal Healthcare with a price target of Rs 358 in its April 02, 2009 research report. “In an effort to reduce costs and restructure its assets in a more efficient manner,.. …

Read More..

LKP Shares has recommended a buy rating on SKF India with an 18-month price target of Rs 190 in its April 04, 2009 research report. “SKF India is the 53.5% subsidiary of the Swedish bearing giant and is the largest bearing producer in India. …

Read More..

Motilal Oswal has maintained its buy rating on Reliance Infrastructure in its April 1, 2009 research report. Reliance Infrastructure, including Reliance Power (45% stake), is targeting to achieve financial closure for projects worth Rs 269 billion by 1QFY10. We expect RELI to report net p…

Read More..

Sharekhan has maintained its buy rating on Shree Cement with a price target of Rs 825 in its April 02, 2009 research report. “Shree Cement has commissioned clinker manufacturing Unit VII of 1MMT capacity at Bangur City, Ras in Pali district of Rajasthan at a capital investment of Rs…

Read More..

Motilal Oswal has maintained its neutral rating on Tata Power Company with a target price of Rs 763 in its April 2, 2009 research report. “We expect Tata Power to report consolidated net profit of Rs 13.6 billion in FY09, Rs 16.6 billion in FY10, and Rs 14.7 billion in FY11. …

Read More..

Sharekhan has maintained its hold rating on Maruti Suzuki India in its April 2, 2009 research report. “In the last couple of months, the demand has received a boost on the back of the significant discounts being offered by the company, the easing of the liquidity crisis and attracti…

Read More..

Reliance Money has maintained its buy rating on Dishman Pharmaceuticals & Chemicals with a target price of Rs 185 in its April 6, 2009 research report. “Dishman Pharmaceuticals & Chemicals Ltd (Dishman), is setting up a Rs 350 million US FDA and MHRA approvable drug formul…

Read More..